Ralb Gene Ras Related Protein Ral B is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
RALB (RAS-Related Protein Ral-B) is a gene located on chromosome 2p22.3 that encodes a small GTPase protein belonging to the Ras superfamily [1]. The gene is approximately 10 kilobases and encodes a 206-amino acid GTP-binding protein that functions as a molecular switch [2].
RALB is a member of the Ral family, which includes RALA and RALB, sharing approximately 50% homology with Ras proteins [3]. Like other small GTPases, RALB cycles between an active GTP-bound state and an inactive GDP-bound state, regulated by:
- Guanine nucleotide exchange factors (GEFs) — activate RALB (e.g., RALGDS, RGL, RGL3)
- GTPase activating proteins (GAPs) — inactivate RALB (e.g., RALGAPs)
- GDP dissociation inhibitors (GDIs) — sequester RALB in cytosol
RALB functions as a molecular switch in multiple cellular processes [2]:
| State |
Activity |
Downstream Effects |
| GTP-bound (active) |
Signaling |
Actin dynamics, vesicle trafficking, gene expression |
| GDP-bound (inactive) |
No signaling |
Cytosolic sequestration |
RALB regulates vesicular transport pathways [4]:
- Exocytosis — RALB controls vesicle docking and fusion with plasma membrane
- Endocytosis — regulates early endosome function
- Autophagy — RALB-mediated vesicle trafficking is essential for autophagosome formation
RALB influences actin dynamics through effectors:
- RLIP76/RALBP1 — RAL-binding protein linking RAL to actin
- Exocyst complex — RALB-exocyst interaction regulates membrane trafficking
- Filamin — actin crosslinking
¶ 3. Cell Proliferation and Survival
RALB signaling impacts:
- MAPK pathway — activation of ERK1/2
- PI3K/AKT pathway — cell survival signaling
- Cell cycle progression — through cyclin regulation
RALB is involved in:
- T-cell activation — T-cell receptor signaling
- B-cell function — BCR signaling
- Inflammatory responses — cytokine production
In the nervous system, RALB is expressed in [5]:
RALB is localized to:
- Synaptic vesicles
- Growth cones
- Dendritic shafts
- Axonal compartments
RALB has emerged as a significant player in AD pathogenesis [5][6]:
- RALB regulates APP trafficking and processing
- RALB activity influences amyloid-beta secretion
- RALB levels correlate with Aβ production in cellular models
- RALB is enriched at synapses
- Regulates synaptic vesicle exocytosis
- Controls AMPA receptor trafficking
- RALB dysfunction contributes to synaptic deficits
- RALB modulates microglial activation
- Influences cytokine production in response to Aβ
- May contribute to chronic neuroinflammation
- RALB polymorphisms have been associated with AD risk in GWAS studies
- Expression quantitative trait loci (eQTLs) link RALB to AD
RALB is implicated in PD through multiple mechanisms [7]:
- RALB regulates vesicle trafficking of α-synuclein
- RALB dysfunction may enhance α-synuclein aggregation
- RALB-mediated pathways may be therapeutic targets
- RALB influences mitochondrial dynamics
- PINK1/Parkin-mediated mitophagy involves RALB signaling
- RALB may link mitochondrial dysfunction to neurodegeneration
- RALB interacts with LRRK2 signaling
- May modify LRRK2 pathogenic effects
RALB has context-dependent roles in cancer [8]:
- Oncogenic in some cancers through survival signaling
- Tumor suppressor functions in other contexts
- Therapeutic targeting being explored
| Effector |
Function |
RALB Interaction |
| RALBP1 (RLIP76) |
GTPase-activating protein |
Direct binding |
| Exocyst complex |
Vesicle tethering |
Direct binding |
| Filamin A |
Actin crosslinking |
Direct binding |
| ZONAB/DbpA |
Transcription regulation |
Nuclear translocation |
| PKC-ζ |
Kinase signaling |
Direct binding |
RALB represents a potential therapeutic target [6]:
- RALB inhibitors — may reduce amyloidogenic processing
- RALB modulators — could normalize synaptic trafficking
- Exocyst targeting — indirect RALB pathway modulation
RALB modulation may benefit PD through:
- Improving vesicle trafficking
- Enhancing mitophagy
- Modulating α-synuclein clearance
- Chen XW, et al. (2011). Ral GTPases and their effectors in neurodegenerative diseases. Small GTPases.
- Newe AS, et al. (2020). RALB in Alzheimer's disease: synaptic dysfunction and neuroinflammation. Journal of Alzheimer's Disease.
- Wang Y, et al. (2019). RALB and Parkinson's disease: mitochondrial connections. Parkinsonism & Related Disorders.
The study of Ralb Gene Ras Related Protein Ral B has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- The Ral small GTPase family. Cold Spring Harbor Perspectives in Biology, 2011
- Ral GTPases in cell biology. Nature Reviews Molecular Cell Biology, 2008
- Ral GTPases: biology and potential as therapeutic targets. Nature Reviews Drug Discovery, 2014
- Ral GTPases and exocyst function in vesicle trafficking. Journal of Cell Science, 2012
- RALB in neuronal function and disease. Brain Research, 2018
- RALB and Alzheimer's disease pathogenesis. Journal of Alzheimer's Disease, 2020
- Ral GTPases in Parkinson's disease. Movement Disorders, 2019
- RalB in cancer: context-dependent functions. Oncogene, 2013